S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Out Of This World Stock Alerts! (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Better Than Oil Stocks? (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Better Than Oil Stocks? (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Out Of This World Stock Alerts! (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Better Than Oil Stocks? (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Better Than Oil Stocks? (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Out Of This World Stock Alerts! (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Better Than Oil Stocks? (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Better Than Oil Stocks? (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Will the Energy Sector Continue to Outshine the Market?
Out Of This World Stock Alerts! (Ad)
Borrowers are reassessing their budgets as student loan payments resume after pandemic pause
In a good sign for China's struggling economy, factory activity grows for the first time in 6 months
Better Than Oil Stocks? (Ad)
MarketBeat Week in Review – 9/25 - 9/29
Cyprus hails Moody's two-notch credit rating upgrade bringing the country into investment grade
Better Than Oil Stocks? (Ad)
Almost all of Nagorno-Karabakh's people have left, Armenia's government says
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
NASDAQ:FGEN

FibroGen (FGEN) SEC Filings & 10K Form

$0.86
-0.11 (-11.31%)
(As of 09/29/2023 ET)
Compare
Today's Range
$0.84
$0.99
50-Day Range
$0.79
$2.09
52-Week Range
$0.70
$25.69
Volume
7.24 million shs
Average Volume
6.02 million shs
Market Capitalization
$84.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.00

Recent FibroGen SEC Filings

DateFilerForm TypeView
09/25/2023
6:37 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
7:54 PM
FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
7:55 PM
Eisner Mark (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
7:55 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2023
6:37 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
6:38 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
4:31 PM
FibroGen (Subject)
Henderson Jeffrey William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2023
4:14 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2023
4:28 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
6:10 PM
FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2023
3:42 PM
FibroGen (Subject)
Henderson Jeffrey William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2023
7:32 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2023
3:47 PM
FibroGen (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G
07/19/2023
6:01 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/13/2023
7:28 PM
FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2023
3:46 PM
FibroGen (Subject)
Henderson Jeffrey William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2023
6:36 PM
Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
3:27 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
8:05 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2023
8:53 PM
FibroGen (Subject)
Wettig Thane (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/22/2023
5:32 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4/A
06/15/2023
7:17 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
5:15 PM
Chung Christine (Reporting)
FibroGen (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2023
6:52 PM
FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
6:53 PM
EDWARDS JEFFREY L (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
6:53 PM
FibroGen (Issuer)
Lema Gerald (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
6:54 PM
FibroGen (Issuer)
Ho Maykin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
6:54 PM
Blaug Suzanne (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
6:55 PM
Brennan Aoife (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
6:56 PM
Cravatt Benjamin (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
7:10 PM
Cravatt Benjamin (Reporting)
FibroGen (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2023
7:11 PM
EDWARDS JEFFREY L (Reporting)
FibroGen (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2023
7:14 PM
Blaug Suzanne (Reporting)
FibroGen (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2023
7:17 PM
Brennan Aoife (Reporting)
FibroGen (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2023
6:51 PM
FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
6:38 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
6:39 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
6:39 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
6:10 PM
Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
6:12 PM
Eisner Mark (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
6:49 PM
FibroGen (Subject)
Graham Juan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/08/2023
4:51 PM
FibroGen (Subject)
Ho Maykin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/08/2023
4:51 PM
FibroGen (Subject)
Henderson Jeffrey William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
8:51 PM
FibroGen (Subject)
Graham Juan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
8:31 PM
Chung Christine (Reporting)
FibroGen (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
8:36 PM
Eisner Mark (Reporting)
FibroGen (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
8:41 PM
FibroGen (Subject)
Wettig Thane (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
9:34 AM
FibroGen (Subject)
Schoeneck James A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
8:00 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2023
7:53 PM
Eisner Mark (Reporting)
FibroGen (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2023
8:00 AM
FibroGen (Filer)
Form DEFA14A
05/18/2023
6:35 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2023
3:59 PM
Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2023
3:32 PM
Eisner Mark (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2023
4:05 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2023
7:27 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2023
3:50 PM
Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 4/A
03/10/2023
8:53 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2023
8:54 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2023
8:55 PM
Eisner Mark (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2023
8:55 PM
Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2023
8:58 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2023
3:29 PM
FibroGen (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/23/2023
7:39 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2023
7:41 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2023
7:42 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2023
7:29 PM
Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2023
7:38 PM
Eisner Mark (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2023
4:26 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 5/A
02/08/2023
9:05 AM
FibroGen (Subject)
FIRST TRUST PORTFOLIOS LP (Filed by)
Form SC 13G/A
02/06/2023
11:37 AM
BlackRock Inc. (Filed by)
FibroGen (Subject)
Form SC 13G/A
02/02/2023
4:22 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/10/2023
3:46 PM
Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2023
5:35 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4/A
01/04/2023
5:33 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4/A
12/28/2022
5:38 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2022
4:23 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2022
4:23 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4/A
12/14/2022
8:55 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2022
6:19 PM
Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2022
6:21 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2022
6:22 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2022
4:41 PM
Eisner Mark (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2022
3:06 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2022
4:06 PM
Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2022
4:30 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:FGEN) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -